Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Irinotecan and Carboplatin in Extensive-Stage SCLC
NCT00104793Phase 2Completed
- Sponsor
- Japan Multinational Trial Organization
- Start
- Jun 2003
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in small cell lung cancer (SCLC), sponsored by Japan Multinational Trial Organization. Started Jun 2003; status: completed.
02
Drugs
irinotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00104793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104793.